DC-CIK（National Taiwan University Hospital）

N/A

Report date: 2022/11/24 20:00:41

Base Information

Drug NameDC-CIK（National Taiwan University Hospital）

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Cytokine-induced killer cellCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy

Mechanisms of ActionNatural killer cell replacements

TargetsNot applicable

Therapy Area/IndicationsLiver Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesNational Taiwan University Hospital

China Registration ClassN/A

Develop Information

Active CompaniesNational Taiwan University Hospital

Inactive CompaniesN/A

Active IndicationsLiver Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A